key: cord-0334851-l0yhxguq
authors: Valente, Michael; Collinet, Nils; Manh, Thien-Phong Vu; Naciri, Karima; Bessou, Gilles; Gil, Laurine; Milpied, Pierre; Tomasello, Elena; Dalod, Marc
title: A novel mouse model based on intersectional genetics enables unambiguous in vivo discrimination between plasmacytoid and other dendritic cells and their comparative characterization
date: 2022-01-08
journal: bioRxiv
DOI: 10.1101/2022.01.07.475382
sha: 94165f189a9bbff5f0217daae8f154a0546efadc
doc_id: 334851
cord_uid: l0yhxguq

Plasmacytoid dendritic cells (pDC) were identified about 20 years ago, based on their unique ability to rapidly produce copious amounts of all subsets of type I and type III interferon (IFN-I/III) upon virus sensing, while being refractory to infection. Yet, the identity and physiological functions of pDC are still a matter of debate, in a large part due to their lack of specific expression of any single cell surface marker or gene that would allow to track them in tissues and to target them in vivo with high specificity and penetrance. Indeed, recent studies showed that previous methods that were used to identify or deplete pDC also targeted other cell types, including pDC-like cells and transitional DC (tDC) that were proposed to be responsible for all the antigen presentation ability previously attributed to steady state pDC. Hence, improving our understanding of the nature and in vivo choreography of pDC physiological functions requires the development of novel tools to unambiguously identify and track these cells, including in comparison to pDC-like cells and tDC. Here, we report successful generation of a pDC-reporter mouse model, by using an intersectional genetic strategy based on the unique co-expression of Siglech and Pacsin1 in pDC. This pDC-Tomato mouse strain allows specific ex vivo and in situ detection of pDC. Breeding them with Zbtb46GFP mice allowed side-by-side purification and transcriptional profiling by single cell RNA sequencing of bona fide pDC, pDC-like cells and tDC, in comparison to type 1 and 2 conventional DC (cDC1 and cDC2), both at steady state and during a viral infection, revealing diverging activation patterns of pDC-like cells and tDC. Finally, by breeding pDC-Tomato mice with Ifnb1EYFP mice, we determined the choreography of pDC recruitment to the micro-anatomical sites of viral replication in the spleen, with initially similar but later divergent behaviors of the pDC that engaged or not into IFN-I production. Our novel pDC-Tomato mouse model, and newly identified gene modules specific to combinations of DC types and activations states, will constitute valuable resources for a deeper understanding of the functional division of labor between DC types and its molecular regulation at homeostasis and during viral infections.

Host survival to viral infections critically depends on type I interferons (IFN-I), which are cytokines endowed both with a direct and strong antiviral activity and with immunoregulatory by infection with SARS-Cov2 is complex, with harmful effects not only of failure to produce IFN-I, but also of delayed/chronic IFN-I production 2, 3 . Hence, understanding the cellular sources of IFN-I during viral infections and their molecular regulation is extremely important to be able to design treatments to boost or on the contrary to dampen this immune response, to promote health over disease depending on the pathophysiological context. Plasmacytoid dendritic cells (pDC) are innate immune cells specialized in the rapid production of high levels of all types of IFN-I in response to many viruses 1, 4 . This process is triggered by the engulfment in pDC of exogenous virus-derived material that is routed into dedicated endosomes equipped with sensors specialized in the recognition of nucleic acids, namely Tolllike receptor 9 (TLR9) for unmethylated CpG DNA and TLR7 for single-stranded RNA. TLR7 and TLR9 then activate a MyD88-to-IRF7 signaling cascade leading to IFN-I production.

However, only a very small fraction of pDC is activated for IFN-I production during viral infections in vivo 5 and we still lack important information on how this process is regulated. In particular, we do not know precisely when, where and how pDC sense viral infection and sample viral-derived material, whether access to viral material is a key limiting step for pDC IFN-I production, and how pDC IFN-I production shapes host antiviral defense 4 . Answering these questions has been hampered by the lack of mutant mouse models enabling specific and penetrant targeting of pDC 6 , to locate them in situ in infected tissues and determine the nature and choreography of their interactions with infected cells or other cell types, to deplete them, or to interrogate their molecular regulation through in vivo gene editing. This bottleneck was largely caused by the fact that no gene is specifically expressed in pDC and not in other cell types, such that genetic targeting of pDC could not be achieved by classical knock-out or knock-in approaches for a single gene. This is all the more the case as, recently, novel DC types were identified that share cell surface marker and gene expression with pDC [7] [8] [9] , including pDC-like cells and transitional DC (tDC), which were often contaminating the cell populations studied as pDC, and which were perturbed by the treatments aimed at targeting pDC, in previous studies. Hence, it is not yet clear to which extent some of the properties attributed to pDC could have been due to their contamination by pDC-like cells or tDC, including cognate activation of T cells and the induction of immune tolerance [7] [8] [9] . Hence, there is an unmet scientific need to generate innovative mutant mouse models for specific and penetrant targeting of pDC 6 , as well as to further characterize pDC-like cells and tDC in comparison to pDC 9 , to help better discriminating these cell types from one another and to lay the foundations for future studies aiming at dissecting their functional specialization.

Here we report the successful design of a pDC-reporter mouse model, enabling unambiguous identification of pDC ex vivo by flow cytometry, and in situ in tissues by confocal microscopy.

Moreover, we illustrate the usefulness of this novel mutant mouse model by harnessing it to determine the choreography of pDC recruitment to the micro-anatomical sites of viral infection in the spleen, before their production of IFN-I, and the later differential behavior of these cells depending on their activation state. We also used this novel mouse model to unambiguously isolate pDC, pDC-like cells and tDC at steady state and during the infection, to compare their gene expression profiles by single cell RNA sequencing (scRNA-seq), with inclusion of type 1 and 2 conventional DC (cDC1 and cDC2) as key reference DC types. Our novel pDC-reporter mouse model and the associated scRNA-seq dataset will constitute precious resources for future research on the in vivo functions of DC types and their molecular regulation.

The generation of mice specifically targeting pDC has been hampered by the lack of any molecule expressed only by pDC, which was confirmed when we attempted to generate pDC reporter mice by targeting the Siglech gene, whose product is highly expressed by mouse pDC 10, 11 . Indeed, fate-mapping of Siglech-targeted cells, using Siglech iCre knock-in mice bred with Rosa26 LoxP-STOP-LoxP(LSL)-RFP mice 12 (Figure 1A) , showed that over 95% of splenic pDC were RFP + ( Figure 1B and S1A-B), but variable proportions of myeloid and lymphoid lineages also expressed RFP ( Figure 1B and S1A-B). Hence, although this strategy enabled extremely efficient targeting of pDC, it was not specific enough, confirming that Siglech is expressed in a fraction of conventional dendritic cells (cDC) or their immediate precursors 13 and in other myeloid cells 14 .

We then reasoned that specific targeting of pDC would be achievable by harnessing intersectional genetics, namely by driving expression of the fluorescent reporter under the control of two genes known to be co-expressed only in pDC. Specifically, we hypothesized that this should be possible if Siglech-driven Cre-recombinase activity activates a conditional fluorescent reporter cassette knocked in the 3'-UTR of a gene exclusively expressed by pDC within Siglech fate-mapped cells. For this purpose, we selected Pacsin1, a gene expressed exclusively in pDC within hematopoietic cells 15 and coding for a molecule involved in the regulation of TLR7/9-dependent IFN-I production by pDC 16 . We thus generated Pacsin1 LoxP-STOP-LoxP-tdTomato (Pacsin1 LSL-tdT ) mice and crossed them with Siglech iCre mice, thereby generating pDC-Tomato mice ( Figure 1C ). In splenocytes from pDC-Tomato mice, tdT was exclusively expressed in pDC, without any specific signal detectable in the other myeloid and lymphoid cells analysed ( Figures 1D and S1A ,C). tdT + cells did not express lineage markers or CD11b ( Figure S1D ). Moreover, the CD45 + tdT + cells isolated from different lymphoid (spleen, lymph nodes) and non-lymphoid organs (intestine, liver) of pDC-Tomato mice uniformly expressed intermediate levels of CD11c and high levels of BST2 ( Figure 1E ), strongly suggesting that they were all pDC 17 . Indeed, CD45 + tdT + cells homogenously co-expressed several markers whose combination is specific to pDC, namely Ly6D, B220, SiglecH and CCR9 ( Figure 1F ).

Altogether, these results show that tdT expression in pDC-Tomato mice is sufficient per se to specifically and unambiguously identify pDC, thus validating our intersectional genetics strategy for specific pDC targeting based on their unique co-expression of Siglech and Pacsin1.

The phenotypic definition of pDC is complex. No single cell marker allows their specific identification. Different research teams use different marker combinations to achieve this aim.

Attempting to define pDC as cells co-expressing CD11c, BST2 and SiglecH can lead to their contamination by cDC, pDC-like cells 7 or tDC 8, 9, 18 , depending on the precise threshold used for individual marker expression levels. This issue is made further complex under inflammatory conditions, since they alter the expression of these markers. For example, during systemic infection by mouse cytomegalovirus (MCMV), CD11c expression levels are increased on pDC and decreased on activated cDC, whereas SiglecH expression is decreased on pDC and BST2 increased on cDC, causing a convergence of the phenotype of pDC and cDC 5 . Hence, we took advantage of the specificity of our novel pDC-Tomato mouse model to seek for an adequate gating strategy allowing unequivocal pDC identification both at steady state and during MCMV infection. To this aim, we defined bona fide pDC as tdT + cells and used the HyperFinder algorithm to identify an unsupervised gating strategy enabling the identification of these cells based exclusively on combinations of cell surface markers, without using their expression of tdT. At steady state, splenic pDC were identified as Bst2 high Ly6D + cells, positive for B220 but negative for CD19, and homogenously expressing CCR9 and SiglecH ( Figure 1G ). During MCMV infection, splenic pDC were identified as Ly6D + cells with varying but not very high levels of CX 3 CR1, positive for CD11c but negative for CD19, and homogenously expressing high levels of CCR9, B220 and BST2 ( Figure 1H ). Taken together, these results indicate that current identification of pDC as lin neg CD11b neg CD11c low-to-int BST2 high cells 17 can be improved by addition of positivity for Ly6D or CCR9 and eventually exclusion of CX 3 CR1 high cells. We thus propose to unambiguously identify pDC in homeostatic and inflammatory conditions as Ly6D + BST2 high CD19 neg B220 + CD11b neg CD11c + cells.

In pDC-Tomato mice, tdT starts to be expressed exclusively in late stages of pDC differentiation We next analysed bone marrow cells to investigate the expression of tdT along the myeloid [19] [20] [21] [22] and lymphoid 7, 8 ontogeny paths that have been proposed for pDC ( Figure 2A ). Within differentiated bone marrow cells, tdT was expressed exclusively in pDC ( Figure 2B) ; it was undetectable in other differentiated immune cell types including cDC, consistent with the results observed in other organs ( Figure 1 ). tdT could also be clearly detected, although at a lower mean fluorescence intensity, in the immediate precursors of pDC, the pre-pDC ( Figure   2C ), defined as Lin neg B220 + CD11c + MHC-II neg FLT3 + BST2 high SiglecH + ( Figure S2A ).

Upstream along the proposed myeloid path of pDC differentiation 13, [19] [20] [21] [22] , very low levels of tdT could be detected in SiglecH + pre-DC, but not in SiglecH neg pre-DC, irrespective of their expression of Ly6C ( Figure 2D and Figure S2A ). This is consistent with SiglecH + Ly6C +/neg pre-DC giving rise to both cDC and pDC, whereas SiglecH neg Ly6C + and SiglecH neg Ly6C neg generate mostly cDC2 versus cDC1 with only few pDC, respectively 13 . Further upstream, the common DC progenitor (CDP), monocyte and DC progenitor (MDP) and common myeloid progenitor (CMP) were negative for tdT expression ( Figure 2E and Figure S2A ).

Upstream along the proposed lymphoid path of pDC differentiation, low but clearly detectable levels of tdT could be detected in CD127 + SiglecH + Ly6D + progenitors ( Figure 2F and Figure   S2B ), consistent with these cells giving rise specifically and efficiently to pDC 7 . Very low levels of tdT could be detected in the upstream Ly6D + SiglecH neg lymphoid progenitor, but not anymore further upstream in the Ly6D neg SiglecH neg lymphoid progenitor ( Figure 2G and Figure   S2B ).

Taken together, our results show that, in pDC-Tomato mice, tdT expression is exclusively induced in late bone marrow precursors already committed to the pDC lineage, with a strong increase of expression in pre-pDC and maximal expression in differentiated pDC.

We next wanted to confirm that tdT expression in pDC-Tomato mice enabled discriminating bona fide pDC from pDC-like cells 7 and tDC 8, 9, 18 . Although refined phenotypic keys have been proposed to discriminate bona fide pDC from pDC-like cells and tDC by flow cytometry at steady state 9 , there is still an unmet need for reporter mouse models allowing their specific tracing under inflammatory conditions as well as in situ in tissues by immunohistofluorescence.

Within hematopoietic cells, the Zbtb46 gene is specifically expressed in the cDC lineage 15 , including in pre-cDC 23 and in pDC-like cells 7 and tDC 9 . This has been confirmed previously in pre-cDC and pDC-like cells by using the Zbtb46 GFP reporter mice 7, 23 . Therefore, to rigorously identify pDC-like cells and tDC in our pDC-Tomato mice, we crossed them with Zbtb46 GFP reporter mice to generate Zbtb46 GFP ;Siglech iCre ;Pacsin1 LSL-tdT animals, hereafter called ZeST mice ( Figure 3A ).

In ZeST mice, most of the lin neg cells expressing high levels of CD11c or being positive for SiglecH expressed either GFP or tdT, in an almost mutually exclusive manner ( Figure 3B ). Within cells expressing tdT or GFP, we identified cDC1 as XCR1 + and cDC2 as CD11b + ( Figure   3B ). Within the XCR1 neg CD11b neg BST2 high SiglecH + gate, we identified pDC as Ly6D + cells, with only a small fraction expressing GFP (Zbtb46 + pDC); pDC-like cells were identified as Ly6D neg GFP +7 . Within the XCR1 neg CD11b neg BST2 neg-to-int SiglecH neg gate, we identified tDC as Ly6D neg CX 3 CR1 + cells 9 ( Figure 3B ). Only very few of the Lin neg , CD11c high or SiglecH + , cells expressed neither GFP nor tdT; yet, a fraction of these cells expressed high levels of both Ly6D and SiglecH, suggesting that they were tdT neg pDC ( Figure 3B ).

To validate the identity of all the cell types identified by manual gating, we further characterized their phenotype ( Figure 3C ). As expected, beyond expressing high levels of Ly6D and being SiglecH + , all pDC populations strongly expressed CCR9 and tdT, while harboring intermediate levels of CD11c. Beyond expressing CX 3 CR1 but not Ly6D, tDC expressed high levels of GFP and were negative for tdT. Beyond expressing SiglecH, BST2 and GFP but not Ly6D, pDClike cells did not express tdT and no or low levels of CCR9. Hence, as expected, tdT was only We performed an unsupervised analysis of the phenotypic relationships between all the Lin neg , CD11c high or SiglecH + , cells by generating a tSNE bi-dimensional representation of the data with FlowJo ( Figure 3D ). We then projected on the tSNE space the populations identified through manual gating as defined in panel B. This analysis identified three main clusters of cells, corresponding to cDC2 (pale blue), cDC1 (dark blue) and pDC (red). The small populations of tdT neg pDC (intermediate blue) and Zbtb46 + pDC (orange) were found in tight proximity to the pDC cluster, consistent with their pDC identity. The pDC-like cells (green) and tDC (purple) settled between the pDC and cDC2 clusters, consistent with previous similar observations 9 .

Finally, we sorted cDC2, tDC, pDC-like cells and pDC from steady state mouse spleens and examined their morphology using confocal microscopy ( Figure 3E ). cDC2 harboured irregular morphologies with many pseudopods or dendrites, translating into a low circularity index. In contrast, the overwhelming majority of pDC-like cells and pDC harboured a rather round morphology, translating into a high circularity index. The tDC population presented a bimodal distribution of circularity indices, with about half of the cells harbouring a dendritic morphology akin to that of cDC2, and the other half a round morphology akin to that of pDC. Hence, quantitative and unbiased analysis of cellular morphology was consistent with success in high degree purification of the different DC types examined when using ZeST mice, but also highlighted the heterogeneity of the tDC population, consistent with its inclusion of two subsets based on their expression pattern of a limited selection of fingerprint genes and cell surface proteins: an Ly6C int/high CD11c low/int MHC-II neg/low pDC-like subset, and a Ly6C neg/low CD11c high MHC-II int/high cDC-like subset 9 .

Altogether, these results confirmed that ZeST mice allowed properly discriminating pDC from pDC-like cells and tDC. Yet, they also unravelled rare fractions of putative pDC devoid of tdT or expressing Zbtb46.

and enabled refining their transcriptomic characterization.

Next, we took advantage of the ZeST mice to perform single cell gene expression profiling of all the five DC types, upon index sorting from the spleen of uninfected animals and of mice that had been infected with MCMV for 36h or 48h, following the gating strategy presented in the previous section, and using the FB5P-seq protocol 24, 25 . We first focused on the analysis of the cells isolated at steady state, to generate DC type-specific signatures to be used for the annotation of the cell clusters of the whole dataset. Following classical technical quality controls, we retrieved 343 cells that were clustered by Seurat based on their gene expression profiles ( Figure S4A ) and by R-phenograph based on their cell surface marker expression as assessed from the index sorting flow cytometry data, without taking tdT expression into account ( Figure S4B ). The 7 clusters were annotated to the DC types based on the expression pattern of archetypic cell surface markers for R-phenograph ( Figure S4C ) and on their marker genes for Seurat. The consistency between the annotations of individual cells as belonging to one of the five DC types based on phenotype (R-Phenograph) versus gene expression (Seurat) was very good ( Figure S4D ). However, Seurat cluster 1 appeared to encompass a mixture of tDC and pDC-like cells, and Seurat cluster 2 of tDC and cDC2, consistent with the known proximity between these DC types, with tDC (Lin neg CD11c + CD11b neg CX 3 CR1 + cells) reported to encompass two subpopulations, one Ly6C int/high CD11c int closer to pDC and the other Ly6C neg/low CD11c high closer to cDC2 9 . Therefore, to identify in a robust and unbiased manner the individual cells that we could unambiguously assign to each of the DC type, we used a combinatorial strategy whereby, to be selected, a cell had to belong to the expected intersection between the R-Phenograph and Seurat clusters (green cells in Figure S4D ) and to be enriched for the corresponding DC type-specific transcriptomic signatures, as established from independent datasets 7, 26 and tested by using the sgCMAP algorithm 27 ( Figure S4E ). This led to a robust final cell type assignment for 205 cells, namely 103 pDC, 26 pDC-like, 19 tDC, 23 cDC2 and 34 cDC1 ( Figure S4E -F). We then generated cell type-specific transcriptomic signatures from this dataset, to corroborate assignment of DC types to the 951 cells from the whole dataset that had passed both quality control and removal of other contaminating cell types ( Figure S5A ). In brief, following cell clustering with Seurat ( Fig. S5A ) and R-Phenograph ( Figure S5B -C), we assigned a DC type to 851 individual cells based on their belonging to the expected intersection between these two clustering strategies ( Figure S5D ). Clustering the 951 cells based on their sgCMAP scores largely confirmed this final cell type assignment ( Figure   S5E ). Importantly, comparing the sorting phenotype of the cells to their final cell type assignment showed that all the cells sorted as pDC remained in fine assigned to pDC when using this unbiased classification scheme ( Fig S5E) . This was also the case for the vast majority of the cells sorted as tdT neg pDC. The assignment of individual cells to cDC1 was also consistent between cell sorting and the a posteriori re-annotation. Clustering of the cells on the sgCMAP scores also tended to confirm the distinction between cDC2 and tDC, although many cells had a null score for the "tDC_vs_cDC2" sgCMAP signature, emphasizing the proximity between these two DC types. In contrast, many cells sorted as Zbtb46 + pDC were pDC-like cells. In addition, some cells sorted as pDC-like were in fine assigned to the tDC type. This analysis led to a robust final cell type assignment for 851 cells, namely 310 pDC, 170 pDClike, 146 tDC, 103 cDC2 and 122 cDC1, with 100 cells left unannotated ( Figure 4A ). These cells expressed the expected pattern of cell surface markers ( Figure 4B ). Of note, both pDClike cells and tDC expressed higher levels of CX 3 CR1 than the other DC types, and lacked CD11b. However, akin to cDC2 (and cDC1), tDC expressed high levels of CD11c and GFP, whereas pDC-like cells expressed SiglecH, BST2, Ly6D and CCR9 to levels intermediate between those of pDC (high) and of cDC (low). As expected, only pDC expressed the signature genes Ccr9, Klk1 and Cox6a2, as well as rearranged immunoglobulin genes ( Figure 4C ). Only pDC expressed tdT above autofluorescence levels ( Figure 4D ). Of note, the fraction of tdT neg pDC is largely over-represented in this figure as compared to their proportions in vivo (see Figure 3B ), because for the FB5P-seq experiment we strongly enriched these rare cells to be able to characterize them. Since we did not use tdT signal to analyse the FB5P-seq dataset, Figure 4C , E) and S100a4 ( Figure 4C ). tDC expressed higher levels of certain cDC genes than pDC and pDC-like, including Batf3, Rogdi and Cyria ( Figure 4C ). Finally, pDClike cells expressed very high levels of Ly6c2 ( Figure 4C , E), consistent with the recent demonstration that Ly6C identifies a tDC subpopulation that resembles more pDC 9 , whereas high expression of CD11c identifies a tDC subpopulation resembling more cDC2 9 as observed in our dataset for tDC when compared to pDC and pDC-like cells ( Figure 4B ). Hence, our results show that the pDC-like cells that we characterize here align with both the pDC-like cells initially described by the team of Roxane Tussiwand 7 , and with the fraction of the tDC population that resembles pDC as described by the teams of Juliana Idoyaga and Boris Reizis 9 , whereas the tDC that we characterize here correspond to the other fraction of the tDC population that resembles cDC2 9 . In conclusion, FB5P-seq confirmed proper identification of pDC, pDC-like cells and tDC in ZeST mice, and enabled refining their characterization by enabling for the first time a side-by-side transcriptomic comparison of these three cell populations, through whole genome expression profiling, at the single cell level, and with inclusion of cDC1 and cDC2 as key reference cell types.

Since flow cytometry on cell suspensions from various organs and scRNA-seq analyses on splenocytes confirmed highly specific and penetrant expression of tdT in pDC from pDC-Tomato mice, we next harnessed this novel and unique pDC-reporter mouse model to determine the micro-anatomical localization of pDC in various organs. In the spleen, a relatively high density of tdT + cells was observed in the T cell zone (TCZ) of the white pulp (WP) marked by a high density of CD3 staining (Figures 5A). Scattered tdT + cells were also detectable in red pulp (RP) areas delimited by CD169 + metallophilic marginal zone (MZ) macrophages and encompassing a high density of F4/80 + cells, most of which are known to be Red Pulp Macrophages ( Figure 5B ). As expected, the overwhelming majority of tdT + splenocytes expressed BST2, both in the TCZ and RP ( Figure 5A -B). However, whereas most BST2 + cells in the TCZ were tdT + ( Figure 5A ), this was not the case in the RP ( Figure 5B ), consistent with known expression of BST2 on other steady state splenocytes, including plasma cells, subsets of macrophages, pDC-like cells and tDC 7, 9, 10 . We then quantified the density of pDC (tdT + cells) in the whole spleen ( Figure Figure 5D ). Around 40% and 30% of splenic pDC were located in the TCZ and RP, respectively, with only smaller fractions of pDC in the BCZ and MZ ( Figure   5E ). Remarkably, however, the density of pDC was much higher in the TCZ (~1500 cells/mm 2 ) than in all other splenic compartments that harboured similar values, at least 3.5 fold lower (≤400 cells/mm 2 ) ( Figure 5C , F). Consistent with their distribution in the spleen, in lymph nodes the pDC were highly frequent in paracortical CD3 + T cell areas ( Figure S6A ). Based on the distribution of cell surface markers thought to be selectively expressed by pDC, such as BST2, previous publications reported that in the small intestine pDC were present both in the Peyer's patches 28 and in the lamina propria (LP) 29 . However, it has been recently shown that other cell types express BST2 in this micro-anatomical compartment, in particular lysozyme Mexpressing macrophages and DC 30, 31 . Hence, BST2 expression cannot be used reliably to determine the micro-anatomical location of pDC in the gut. Therefore, we analysed tissue sections of the small intestine from pDC-Tomato mice to re-examine the micro-anatomical location of pDC in this organ. tdT + cells were detectable in the LP, preferentially in areas proximal to the EpCAM + epithelial cell layer ( Figure S6B ). Only very few tdT + cells were observed in Peyer's patches ( Figure S6C ). Differently from the small intestine, pDC were not detectable in the LP of the large intestine ( Figure S6D ). These results indicate that, at steady state, in the gut, bona fide pDC are detectable exclusively in the LP of the villi of the small intestine; they are absent from the large intestine and from the organized lymphoid structures of the gut including Peyer's patches.

By combining the use of Ifnb1 EYFP reporter mice 32 with scRNA-seq, flow cytometry and confocal microscopy 24 , we recently determined the activation trajectory of splenic IFN-I-producing pDC in vivo during MCMV infection. In particular, we showed their clustering in the MZ near to infected cells at the time of peak IFN-I production, followed by their migration to the TCZ after termination of their IFN-I production and acquisition of transcriptomic, phenotypic and functional features of mature DCs. However, the lack of adequate markers prevented us from assessing the spatiotemporal repositioning of the pDC that were not producing IFN-I. To answer this question, we bred pDC-Tomato mice with Ifnb1 EYFP reporter animals, hence generating SiglecH iCre ;Ifnb1 EYFP ;Pacsin1 LSL-tdT mice, hereinafter called SCRIPT mice ( Figure   6A ). In SCRIPT mice, we can thus unambiguously identify both the pDC that produce IFN-I (tdT + YFP + ) and those that do not (tdT + YFP neg ), for the first time to our knowledge ( Figures   6A-B) . By flow cytometry, both tdT + YFP neg and tdT + YFP + cells were detectable in splenocyte suspensions 36 and 48 hours after MCMV infection, with tdT + YFP + representing 20-25 % of the total splenic pDC (tdT + ) population ( Figure 6B ). Both populations expressed comparable high levels of Ly6D and BST2, consistent with their pDC identity ( Figure 6B ). We also detected rare tdT neg YFP + Ly6D neg BST2 low cells. These data are consistent with our previous work 5, 17, 24, 33 , confirming that pDC are the main source of IFN-I during MCMV infection, with other cell types only marginally contributing to this production. Next, we examined the localization of both tdT + YFP neg and tdT + YFP + pDC in spleens from MCMV-infected mice, by using confocal microscopy ( Figures 6C-F 5 . Activation increased autofluorescence in other DC types but did not induce their expression of tdT ( Figure 8B ). pDC also remained characterized by their uniquely high levels of Ly6D and CCR9 expression as compared to the other DC types, across activation states. In contrast, BST2 expression increased on all activated DC types ( Figure   8B ), as reported previously 5, 34, 35 , leading to a strong overlap of BST2 expression levels between activated pDC and pDC-like cells. Activation decreased CX 3 CR1 expression in tDC ( Figure S8 ), which, in conjunction with the increased BST2 expression (Figure 8B ), made their phenotypic discrimination from pDC-like cells more difficult, although CD11c and GFP expression remained higher on tDC than on pDC-like cells ( Figure S8A ). Although XCR1 expression on cDC1 and CD11b on cDC2 decreased with activation, they remained clearly detectable, still allowing phenotypic identification of these DC types ( Figure S8A ).

In the UMAP space, quiescent tDC and pDC-like cells were close to one another, between pDC and cDC2 ( Figure 8A ), as observed in previous reports in UMAP spaces drawn from flow cytometry or bulk RNA-seq data 9 . Strikingly, however, upon activation they moved towards These genes were induced to similar levels in IFN-I-producing pDC and in activated pDC-like cells, but to even higher levels in activated tDC, cDC2 and cDC1. Only few genes were found to be differentially expressed between tDC and cDC2: 16 at steady state, 1 at the intermediate activation state, and 11 for activated cells. Whereas only 84 genes were differentially expressed between tDC and pDC-like cells at steady state, this number increased to 527 for activated cells. In contrast, the number of genes differentially expressed between pDC and pDC-like remained stable over activation, 113 at steady state versus 138 in activated cells.

Hence, this analysis confirmed the divergent activation patterns for pDC-like cells and tDC suggested by the UMAP, with pDC-like cells behaving closer to pDC, although not producing IFN-I ( Figure 8C , cluster 5), whereas tDC converging further towards cDC2.

Expression of the Ly6c2 gene remained much higher in pDC-like cells than in tDC ( Figure   S8B ), suggesting that the distinction between pDC-like cells and tDC based on their reciprocal expression levels of CD11c ( Figure S8A ) and Ly6C as observed in steady state 9 could hold under activation conditions. Genes encoding MHC-II molecules were consistently higher in tDC than in pDC-like cells, reaching the same levels as observed in cDC2, as illustrated for H2-DMb2 and H2-Eb1 ( Figure S8B ). The genes Tmem176a and Tmem176b, encoding cell surface markers, were consistently and significantly higher in tDC than in pDC-like cells, pDC and cDC1 across activation conditions and also tended to be lower in cDC2 than tDC ( Figure   S8B ). Hence, we here identified Tmem176a and Tmem176b as candidate markers specific for tDC. Expression of Cd8a remained lower in cDC2 than in other DC types across activation conditions ( Figure S8B ). The gene Ms4a4c was higher in activated pDC-like cells, intermediate and activated tDC and cDC2 than in pDC and cDC1 ( Figure S8B ). One gene, Apod, was exclusively expressed to high levels in pDC-like cells above all other DC types across activation conditions ( Figure S8B ). Il18 and Il12b ( Figure S8B ). This is consistent with a division of labor between DC types, with cDC1 playing a unique and non-redundant role in promoting NK cell antiviral activity and accelerating CD8 + T cell responses during MCMV infection [36] [37] [38] [39] .

In a review on how genetic models of DC development enable correlating ontogeny with function, Pr. Kenneth Murphy, an international leader in this research field, stated that "pDC function is still a black box" because "a model of pDC-restricted functional or developmental impairment [remains to be] developed" 6 . Indeed, the lack of mutant mouse models enabling to specifically target pDC has hampered our understanding of their physiological functions, their choreography in vivo and their molecular regulation. This is all the more the case since, when classical markers are used for identification, pDC can be contaminated with other cell types reported to be much more powerful than resting pDC for T cell activation 7-9 , including pDC-like cells and tDC. This recent discovery has put into questions some of the conclusions previously drawn on pDC, because these cell types can also be affected in the experimental settings previously used to deplete pDC. The injection of anti-GR1 or -Ly6C or -BST2 antibodies should especially affect pDC-like cells, in addition to subsets of neutrophils, monocytes or macrophages. The use of the CD11c-Cre;Tcf4-fl/fl mouse model also leads to tDC depletion 9 .

This would also be expected in SiglecH-DTR mice where other cell type are already known to be affected, including DC and subsets of macrophages 14 . For the same reason, and because pDC downregulate SiglecH upon activation, the use of Siglech-GFP reporter mice to track pDC in vivo is inadequate 14 . Although GFP expression is high and penetrant in pDC from the DPE GFP mice 40, 41 , this model is inadequate to track pDC in vivo, since T and NK T cells also strongly express GFP that is under the control of the distal and proximal CD4 enhancers and CD4 promoter 42, 43 . Moreover, other myeloid cells express the Cd4 gene including subsets of cDC2 and of macrophages 30 . Thus, novel tools are required to specifically identify, characterize and manipulate pDC in vivo, including to discriminate them from tDC that strongly infiltrate inflamed tissues 9, 44 . However, this aim has been difficult to achieve because no single gene has been found to be expressed specifically in pDC. Hence, to overcome this bottleneck, we devised an intersectional genetic strategy based on the unique co-expression of Siglech and Pacsin1 in pDC 15 . Indeed, whereas Siglech is also expressed in pDC-like cells, DC precursors and subsets of macrophages, this is not the case of Pacsin1 whose expression is otherwise confined to neurons. Hence; we report here the generation and characterization of pDCreporter mice as Siglech iCre ;Pacsin1 LSL-tdT animals. features of classical DC maturation akin to that occurring in cDC2 and cDC1. We report the identification of gene modules induced during activation selectively in a given DC type, or in specific combinations of DC types. This dataset should be a valuable resource to mine in the coming years to infer from their specific gene expression programs hypotheses on the functional specialization of pDC-like cells and tDC, as compared to pDC, cDC1 and cDC2, at steady state and during a viral infection in vivo, and on their molecular regulation. We identified Tmem176a and Tmem176b as novel putative cell surface markers specific to tDC, which should help studying these cells in a more specific manner to understand their functions.

Interestingly, these molecules have been reported to promote MHC-II antigen presentation to naïve CD4 T cells 45 and MHC-I antigen cross-presentation to CD8 T cells, in a manner that may contribute to immunosuppression in tumors 46 or to tolerance to allografts 47, 48 .

Interestingly, Tmem176a/b were shown to strongly co-localize with HLA-DM in the late endolysosomal system, and, here, we show that tDC and cDC2 express higher levels of both Tmem176a/b and H2.DMb2 than other DC types. This suggests the hypothesis of a possible functional specialization of tDC in the induction of CD4 T cell tolerance, and raises the question of the division of labor between tDC and cDC2. Based on the specific gene modules that we have identified here, these questions might be addressed in future studies, once mutant mouse models have been designed to specifically target tDC or cDC2.

Finally, our work opens the exciting perspective to now generate new mutant mouse models for specific and penetrant constitutive ablation of pDC, as Siglech iCre ;Pacsin1 LSL-Dta mice. It will also be exciting to try harnessing this intersectional genetic strategy to engineer a mouse model for binary Cre-mediated genetic editing specifically in pDC 49 . These mouse models should then be key to allow us better understanding the physiological functions of pDC in future studies.

All animal experiments were performed in accordance with national and international laws for Zbtb46 GFP ;Siglech iCre ;Pacsin1 LSL-tdT (ZeST) mice were generated by crossing Zbtb46 GFP mice (B6.129S6(C)-Zbtb46 tm1.1Kmm/J ) 23 with pDC-Tomato mice and were used at a heterozygous state. All animals used were sex-and age-matched (used between 8-16 weeks of age).

Virus stocks were prepared from salivary gland extracts of 3-weeks old MCMV-infected BALB/c mice. All mice used in the experiments were infected i.p. with 10 5 pfu Smith MCMV and sacrificed at indicated time points.

Spleens or lymph nodes were harvested and submitted to enzymatic digestion for 25 minutes at 37°C with Collagenase IV (Wortington biochemicals) and DNAse I (Roche Diagnostics).

Organs were then mechanically digested and passed over 100µm cell strainers (Corning). Red For the unsupervised analysis, tSNE plots were generated with the dedicated plugin in the software. Dimensional reduction was performed on Singlets/Non Autofluorescent/Live Dead neg /Lineage neg /CD19 neg /CD11c + and/or SiglecH + cells. Dimension reduction was calculated with the following markers: B220, BST2, CD11b, CD11c, CCR9, CX 3 CR1, Ly6D, SiglecH, tdT, XCR1 and Zbtb46-GFP. For the generation of unsupervised gating strategy, the plugin Hyperfinder was used. The calculation was performed on Singlets/Non Autofluorescent/Live Dead neg cells. We defined the pDC population for the calculation as being Lineage neg /CD19 neg / CD11b neg /XCR1 neg /CD11c low /BST2 high /tdT + . The software calculated the best and fastest gating strategy with the following markers: B220, BST2, CD11b, CD11c, CD19, CCR9, CX 3 CR1, Lineage (CD3/Ly6G/NK1.1) Ly6D, SiglecH and XCR1.

For the generation of the scRNAseq data, we followed the FB5P previously published method 25 . Briefly, single cells were FACS-sorted into ice-cold 96-well PCR plates (Thermofisher) containing 2µl lysis mix per well. Immediately after cell sorting, each plate was covered with an adhesive film (Thermofisher), briefly spun down in a benchtop plate centrifuge, and frozen on dry ice. The reverse transcription reaction was performed with SuperScript II (Thermofisher) in presence of RnaseOUT (Thermofisher), DTT (Thermofisher), betaine (Sigma-Aldrich), MgCl2 (Sigma-Aldrich), and well-specific template switching oligonucleotide. 

FB5P sequencing data were processed to generate a single-cell UMI counts matrix as described 25 . The counts matrix was loaded to R (v.4.0.3), and Seurat (v3.2.0) 50 was used for downstream analyses as described 24 . Gene expression is shown as log-normalized values and protein expression as inverse hyperbolic arcsine (asinh) of fluorescence intensity scaled values (asinh(fluorescence/100)). For dimensionality reduction, we performed uniform manifold approximations and projections (UMAP), using the RunUMAP function. The differentially expressed genes were determined using the FindMarkers function.

A first Seurat analysis was performed only on cells from uninfected mice (345 cells after QC, 2 of which were removed due to lack of index sorting data). Clusters were identified based on gene expression using Seurat (k-nearest neighbor=5; resolution=0.2) or based on phenotypic marker expression using Rphenograph 51 (v0.99.1) (number of nearest neighbours k=20), taking into account the protein expression for GFP, B220, Ly6D, XCR1, CX 3 CR1, BST2, SiglecH, CCR9, CD11b and CD11c (but not for tdTomato). A single cell connectivity Map (sgCMap) analysis was performed on this dataset using cell type-specific signatures (tDC, cDC2, cDC1, pDC) established upon re-analysis with BubbleGUM GeneSign module 52 Clusters were identified based on gene expression using Seurat (k-nearest neighbor=9; resolution=0.7) or based on phenotypic marker expression using Rphenograph (number of nearest neighbours k=50). Integration of Seurat and Phenograph clusters allowed to identify unambiguous cell types and activation states (851 total cells), which was corroborated upon performing a single cell cMap analysis using the relative signatures identified in the previous step. The genes differentially expressed between cell types at equivalent activation states or between activation states for a given cell type were then extracted, using the FindMarkers function (default parameters, threshold for adjusted p-value<0.05).

The heatmaps were plotted using the Gene-E program.

Organs were fixed with Antigen Fix (Diapath) for 2 hours for the small intestine, colon, lymph Whole sections were acquired by spectral confocal microscope (Zeiss LSM 880) with 20x or 40x objectives. Pictures were then analyzed with ImageJ, including through the development of several specific macros available on demand to the corresponding authors. The T cell zone was defined as a CD3-rich region within the white pulp. The B cell zone was defined as a B220rich area within the white pulp. The red pulp was defined as an F4/80-rich region and the marginal zone was defined as the space between the CD169 and F4/80 stainings. For the calculation of pDC counts per mm 2 , the function "analyze particles" was used and a threshold for tdT intensity and the size (above 8m 2 ) was applied. For the quantification of the repartition of pDC upon infection, the intensity of tdT was calculated in the different zones after a threshold for the intensity was applied. A ratio between the intensity in each zone and the total intensity of the whole section was then calculated.

The different cell subsets were FACS sorted in cold 5ml FACS tube containing 1ml of RPMI supplemented with 10% fetal calf serum, 1% L-glutamine (Gibco), 100 U ml−1 of penicillinstreptomycin, 1% nonessential amino acids, 1% sodium pyruvate and 0.05 mM βmercaptoethanol. After washing in PBS, cells were resuspended in RPMI 1% FCS. 1.000 to 50.000 cells were allowed to adhere for 1 hour at 37°C to coverslips coated with 5 μg/cm 2 

A) Dimensionality reduction of the gene expression data performed using the UMAP algorithm with the Seurat pipeline for DC types isolated from the spleens of three ZeST (Zbtb46 GFP ;Siglech iCre ;Rosa26 LSL-tdT ) mice (one uninfected, one MCMV-infected for 36h and the third infected for 48h). Cells were index sorted into the 5 DC types studied using the gating strategy presented in Figure 3B , and used for single cell RNA sequencing using the FB5P-seq procedure. Cells that did not pass the FB5P-seq quality controls or that turned out to be contaminants were removed from the analysis, leading to keeping 951 cells. 

Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation

Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19

Plasmacytoid Dendritic Cells: Development, Regulation, and Function

Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection

Models of dendritic cell development correlate ontogeny with function

Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells

Plasmacytoid dendritic cells develop from Ly6D(+) lymphoid progenitors distinct from the myeloid lineage

Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population

Siglec-H is an IPCspecific receptor that modulates type I IFN secretion through DAP12

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors

Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies

Identification of cDC1-and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow

Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells

Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells

Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection

CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells

Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo

Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow

A clonogenic bone marrow progenitor specific for macrophages and dendritic cells

CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation

Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages

The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection

FB5P-seq: FACS-Based 5-Prime End Single-Cell RNA-seq for Integrative Analysis of Transcriptome and Antigen Receptor Repertoire in B and T Cells

Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses

Mapping the human DC lineage through the integration of highdimensional techniques

Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype

CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine

Innate and adaptive immune functions of peyer's patch monocytederived cells

The Peyer's Patch Mononuclear Phagocyte System at Steady State and during Infection

Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo

Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo

Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody

Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation

Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta

Functional interactions between dendritic cells and NK cells during viral infection

Batf3 transcription factordependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation

Natural killer cells and dendritic epidermal gammadelta T cells orchestrate type 1 conventional DC spatiotemporal repositioning toward CD8(+) T cells

Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide

Characterization of Resident Corneal Plasmacytoid Dendritic Cells and Their Pivotal Role in Herpes Simplex Keratitis

A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation

Dendritic Cells Require TMEM176A/B Ion Channels for Optimal MHC Class II Antigen Presentation to Naive CD4(+) T Cells

Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation

Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation

Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts

A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis

BubbleGUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses

We thank CIPHE for the generation of Siglech iCre and Pacsin1 LSL-tdT mice and their assistance in the breeding of mice, as well as the staff of the CIML mouse houses, flow cytometry, histology, genomics bioinformatics and imaging (ImagImm) core facilities. We thank S. Henri (CIML) for the generous gift of the Zbtb46 GFP mice. We thank the two Master trainees, Alex Trinh and Dylan Anselmo, for technical assistance in some experiments. This research was funded by grants from the Fondation pour la Recherche Médicale (grants no.DEQ20110421284 and DEQ20180339172, Equipe Labellisée, to M.D.). We also thank the